药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Insulin detemir
Dimethyltryptamine
The risk or severity of adverse effects can be increased when Dimethyltryptamine is combined with Levomilnacipran.
Insulin detemir
4-Bromo-2,5-dimethoxyamphetamine
The risk or severity of adverse effects can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Levomilnacipran.
Insulin detemir
4-Methoxyamphetamine
The risk or severity of adverse effects can be increased when 4-Methoxyamphetamine is combined with Levomilnacipran.
Insulin detemir
Fencamfamin
The risk or severity of adverse effects can be increased when Fencamfamin is combined with Levomilnacipran.
Insulin detemir
Bufotenine
The risk or severity of adverse effects can be increased when Bufotenine is combined with Levomilnacipran.
Insulin detemir
JNJ-26489112
The risk or severity of adverse effects can be increased when Levomilnacipran is combined with JNJ-26489112.
Insulin detemir
Bentazepam
The risk or severity of adverse effects can be increased when Bentazepam is combined with Levomilnacipran.
Insulin detemir
Pyrazolam
The risk or severity of adverse effects can be increased when Pyrazolam is combined with Levomilnacipran.
Insulin detemir
Cinazepam
The risk or severity of adverse effects can be increased when Cinazepam is combined with Levomilnacipran.
Insulin detemir
Oxazepam acetate
The risk or severity of adverse effects can be increased when Oxazepam acetate is combined with Levomilnacipran.
Insulin detemir
Perphenazine enanthate
The risk or severity of adverse effects can be increased when Perphenazine enanthate is combined with Levomilnacipran.
Insulin detemir
Cannabidivarin
The risk or severity of adverse effects can be increased when Cannabidivarin is combined with Levomilnacipran.
Insulin detemir
5-methoxy-N,N-dimethyltryptamine
The risk or severity of adverse effects can be increased when 5-methoxy-N,N-dimethyltryptamine is combined with Levomilnacipran.
Insulin detemir
MRK-409
The risk or severity of adverse effects can be increased when MRK-409 is combined with Levomilnacipran.
Insulin detemir
Cyclopropane
The risk or severity of adverse effects can be increased when Cyclopropane is combined with Levomilnacipran.
Insulin detemir
N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine
The risk or severity of adverse effects can be increased when N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine is combined with Levomilnacipran.
Insulin detemir
2,5-Dimethoxy-4-ethylthioamphetamine
The risk or severity of adverse effects can be increased when 2,5-Dimethoxy-4-ethylthioamphetamine is combined with Levomilnacipran.
Insulin detemir
Lormetazepam
The risk or severity of adverse effects can be increased when Lormetazepam is combined with Levomilnacipran.
Insulin detemir
Doxefazepam
The risk or severity of adverse effects can be increased when Doxefazepam is combined with Levomilnacipran.
Insulin detemir
Carbromal
The risk or severity of adverse effects can be increased when Carbromal is combined with Levomilnacipran.